We are live on ! Find out more
BA

Boston Advisors Portfolio holdings

AUM $1.91B
1-Year Est. Return 6.26%
This Fund
S&P 500
This Quarter Est. Return
+0.93%
1 Year Est. Return
+6.26%
3 Year Est. Return
+73.82%
5 Year Est. Return
+112.87%
10 Year Est. Return
AUM
$4.06B
AUM Growth
-$216M
Cap. Flow
-$186M
Cap. Flow %
-4.57%
Top 10 Hldgs %
19.83%
Holding
736
New
89
Increased
195
Reduced
242
Closed
87

Top Buys

Rank Stock Value
1
ABBV icon
AbbVie
ABBV
+$35.7M
2
JNJ icon
Johnson & Johnson
JNJ
+$26.2M
3
LLL
L3 Technologies, Inc.
LLL
+$25M
4
CLX icon
Clorox
CLX
+$21.2M
5
V icon
Visa
V
+$21M

Top Sells

Rank Stock Value
1
MA icon
Mastercard
MA
+$47.9M
2
AMZN icon
Amazon
AMZN
+$31M
3
AGN
Allergan plc
AGN
+$26.5M
4
CTSH icon
Cognizant
CTSH
+$22.3M
5
UAL icon
United Airlines
UAL
+$20.1M

Sector Composition

Rank Sector Weight
1 Healthcare 17.26%
2 Technology 13.82%
3 Financials 10.83%
4 Communication Services 10.67%
5 Consumer Staples 9.97%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BRCM
626
DELISTED
BROADCOM CORP CL-A
BRCM
-242,450
Closed -$14M
DYAX
627
DELISTED
DYAX CORPORATION
DYAX
-430,645
Closed -$16.2M
MITSY
628
DELISTED
MITSUI & CO LTD ADR (US)
MITSY
-1,364
Closed -$328K
KNBWY
629
DELISTED
KIRIN BREWERY LTD SPONSORED ADR
KNBWY
-18,634
Closed -$255K
CB
630
DELISTED
CHUBB CORPORATION
CB
-3,160
Closed -$419K

Similar funds

Boston Advisors's Q1 2016 Portfolio in Review

As of Q1 2016, Boston Advisors held 736 positions worth $4.06B, down 5.1% from $4.28B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Boston Advisors withdrew a net $186M in Q1 2016, closing 87 positions and reducing 242 holdings. Its most notable exit was DYAX CORPORATION, an estimated $16.2M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 17% of assets, up from 17% a quarter earlier, followed by Technology and Financials.

Against the trend, Boston Advisors opened a new position in Baxter International worth $16.4M.

  • Boston Advisors's largest Q1 2016 buy was Baxter International: 399,091 shares worth $16.4M.
  • Boston Advisors added most to AbbVie in Q1 2016, an estimated $35.7M increase.
  • Boston Advisors's biggest Q1 2016 reduction was Mastercard, cutting an estimated $47.9M.
  • Boston Advisors fully exited DYAX CORPORATION in Q1 2016, selling an estimated $16.2M.
  • Boston Advisors's ten largest holdings make up 20% of its $4.06B portfolio in Q1 2016.
  • Boston Advisors opened 89 new positions and closed 87 in Q1 2016.
  • Boston Advisors's portfolio value fell 5.1% quarter-over-quarter to $4.06B.

Based on Boston Advisors's 13F filing for Q1 2016, filed 20 Apr 2016.